Inventor · disambiguated record
Ny Sin
Also filed as: SIN NY
28 granted patents·12 pending applications·816 citations·filing 2000–2023
97Inventor score
Files withBRISTOL MYERS SQUIBB CO21VIIV HEALTHCARE UK NO 5 LTD6VIIV HEALTHCARE UK NO 4 LTD4REGUEIRO-REN ALICIA3UNIV CALIFORNIA3
Top patents by PatentIndex Score
40 records- 0198US7449479B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Nov 11, 2008·67 cites·16 claims
- 0298US6995174B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 7, 2006·194 cites·48 claims
- 0397US7915291B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Mar 29, 2011·40 cites·21 claims
- 0497US7323447B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 29, 2008·50 cites·26 claims
- 0596US7041698B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 9, 2006·135 cites·19 claims
- 0696US6831099B1Enzyme inhibitionUNIV YALE·Filed 2000·Granted Dec 14, 2004·109 cites·21 claims
- 0794US7135462B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 14, 2006·72 cites·54 claims
- 0893US9527882B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2015·Granted Dec 27, 2016·6 cites·18 claims
- 0993US8299094B2Hepatitis C virus inhibitorsWANG ALAN XIANGDONG·Filed 2010·Granted Oct 30, 2012·15 cites·11 claims
- 1092US8846647B2C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activityREGUEIRO-REN ALICIA·Filed 2012·Granted Sep 30, 2014·19 cites·16 claims
- 1192US8710229B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 29, 2014·10 cites·3 claims
- 1290US7772180B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 10, 2010·17 cites·20 claims
- 1389US8754068B2Modified C-3 betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2011·Granted Jun 17, 2014·15 cites·24 claims
- 1488US8802661B2C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitorsREGUEIRO-REN ALICIA·Filed 2011·Granted Aug 12, 2014·14 cites·22 claims
- 1585US11084845B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2019·Granted Aug 10, 2021·1 cites·8 claims
- 1684US9227940B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 5, 2016·3 cites·2 claims
- 1784US6489338B2Imidazopyridine and imidazopyrimidine antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Dec 3, 2002·25 cites·7 claims
- 1883US10421774B2C-3 and C-17 modified triterpenoids as HIV-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Granted Sep 24, 2019·1 cites·4 claims
- 1983US8889871B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 18, 2014·3 cites·1 claims
- 2081US8163921B2Hepatitis C virus inhibitorsSIN NY·Filed 2009·Granted Apr 24, 2012·9 cites·16 claims
- 2180US7592336B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Sep 22, 2009·4 cites·18 claims
- 2277US9636375B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 2, 2017·1 cites·1 claims
- 2377US2023295220A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2022·Application pending·0 cites
- 2476US10780102B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2019·Granted Sep 22, 2020·0 cites·3 claims
- 2574US2024199604A1Supramolecular polymer therapeutics and diagnosticsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2674US2024197682A1Method for treating neurological diseases using supramolecule polymer therapeuticsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2774US2024201205A1Method for detecting neurological diseases using supramolecule polymer therapeuticsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 2873US6774134B2Heterocyclic substituted 2-methyl-benzimidazole antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Aug 10, 2004·5 cites·7 claims
- 2972US8889854B2C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Nov 18, 2014·1 cites·18 claims
- 3071US2021323997A1C-3 and c-17 modified triterpenoids as hiv-1 inhibitorsVIIV HEALTHCARE UK NO 5 LTD·Filed 2021·Application pending·0 cites
- 3169US10245275B2Triterpenoids with HIV maturation inhibitory activityVIIV HEALTHCARE UK NO 4 LTD·Filed 2017·Granted Apr 2, 2019·0 cites·4 claims
- 3265US2017056420A1Triterpenoids with hiv maturation inhibitory activityVIIV HEALTHCARE UK (NO 4) LTD·Filed 2016·Application pending·0 cites
- 3359US2014343000A1Compositions having c-17 and c-3 modified triterpenoids with hiv maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 3452US2009285774A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 3550US2016151387A1Compositions having c-17 and c-3 modified triterpenoids with hiv maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 3649US6844342B2Heterocyclic substituted 2-methyl-benzimidazole antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 18, 2005·0 cites·8 claims
- 3745US2019135857A1Triterpenoid inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Application pending·0 cites
- 3845US2014221361A1C-19 modified triterpenoids with hiv maturation inhibitory activityBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 3944US2007161670A1Process for the preparation of substituted heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 4036US10047118B2C17-aryl substituted betulinic acid analogsVIIV HEALTHCARE UK NO 5 LTD·Filed 2015·Granted Aug 14, 2018·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →